Acerus Pharmaceuticals

Patent cliffs & loss of exclusivity

Men's / Women's Health

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/acerus-pharmaceuticals-corporation
Full Address2486 DUNWIN DR MISSISSAUGA, ON L5L 1J9 CANADA
LinkedIn URLhttps://www.linkedin.com/company/acerus-pharma
Pitchbook URLhttps://pitchbook.com/profiles/company/59652-73
Twitter URLhttps://twitter.com/aceruspharma
Official Websitehttp://aceruspharma.com/english/home/default.aspx

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. NOCTIVADESMOPRESSIN ACETATESmall mol.Jun 2030
  2. NOCTIVADESMOPRESSIN ACETATESmall mol.Jun 2030
  3. NATESTOTESTOSTERONESmall mol.Mar 2034

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.